Literature DB >> 19875978

Overdose deaths involving prescription opioids among Medicaid enrollees - Washington, 2004-2007.

.   

Abstract

During 1999-2006, the number of poisoning deaths in the United States nearly doubled, from approximately 20,000 to 37,000, largely because of overdose deaths involving prescription opioid painkillers. This increase coincided with a nearly fourfold increase in the use of prescription opioids nationally. In Washington, in 2006, the rate of poisoning involving opioid painkillers was significantly higher than the national rate. To better characterize the prescription opioids associated with these deaths and to reexamine previously published results indicating higher drug overdose rates in lower-income populations, health and human services agencies in Washington analyzed overdose deaths involving prescription opioids during 2004-2007. This report describes the results of that analysis, which found that 1,668 persons died from prescription opioid-related overdoses during the period (6.4 deaths per 100,000 per year); 58.9% of decedents were male, the highest percentage of deaths (34.4%) was among persons aged 45-54 years, and 45.4% of deaths were among persons enrolled in Medicaid. The age-adjusted rate of death was 30.8 per 100,000 in the Medicaid-enrolled population, compared with 4.0 per 100,000 in the non-Medicaid population, an age-adjusted relative risk of 5.7. Methadone, oxycodone, and hydrocodone were involved in 64.0%, 22.9%, and 13.9% of deaths, respectively. These findings highlight the prominence of methadone in prescription opioid--related overdose deaths and indicate that the Medicaid population is at high risk. Efforts to minimize this risk should focus on assessing the patterns of opioid prescribing to Medicaid enrollees and intervening with Medicaid enrollees who appear to be misusing these drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875978

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  58 in total

1.  New Perspectives in the Treatment of Opioid-Induced Respiratory Depression.

Authors:  Loretta Fala; John A Welz
Journal:  Am Health Drug Benefits       Date:  2015-10

2.  Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk.

Authors:  Rebecca B Naumann; Andrew W Roberts; Stephen W Marshall; Asheley C Skinner
Journal:  Med Care       Date:  2019-03       Impact factor: 2.983

3.  Goals and Objectives to Optimize the Value of an Acute Pain Service in Perioperative Pain Management.

Authors:  Linda Le-Wendling; Wesley Glick; Patrick Tighe
Journal:  Tech Orthop       Date:  2017-12

4.  Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.

Authors:  Rachel Springer; Miguel Marino; Steffani R Bailey; Heather Angier; Jean P O'Malley; Megan Hoopes; Stephan Lindner; Jennifer E DeVoe; Nathalie Huguet
Journal:  Addiction       Date:  2019-06-30       Impact factor: 6.526

5.  High-Risk Prescribing to Medicaid Enrollees Receiving Opioid Analgesics: Individual- and County-Level Factors.

Authors:  Sara E Heins; Mark J Sorbero; Christopher M Jones; Andrew W Dick; Bradley D Stein
Journal:  Subst Use Misuse       Date:  2018-01-05       Impact factor: 2.164

6.  Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.

Authors:  Merav Kovatch; Daniel Feingold; Odelia Elkana; Shaul Lev-Ran
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-23       Impact factor: 4.035

7.  Use and Opinions of Prescription Opioids Among Older American Adults: Sociodemographic Predictors.

Authors:  Hanna Grol-Prokopczyk
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2019-08-21       Impact factor: 4.077

8.  Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015.

Authors:  Enihomo Obadan-Udoh; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Ulrike Muench; Matthew Jura; Hyunjee Kim; Eli Schwarz; Elizabeth Mertz; Benjamin C Sun
Journal:  J Am Dent Assoc       Date:  2019-04       Impact factor: 3.634

9.  Prescription drug monitoring program inquiry in psychiatric assessment: detection of high rates of opioid prescribing to a dual diagnosis population.

Authors:  Daniel T Hackman; Marion S Greene; Taya J Fernandes; Ashley M Brown; Eric R Wright; R Andrew Chambers
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

10.  Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities.

Authors:  Bradley D Stein; Joshua Mendelsohn; Adam J Gordon; Andrew W Dick; Rachel M Burns; Mark Sorbero; Regina A Shih; Rosalie Liccardo Pacula
Journal:  J Addict Dis       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.